Log in

CVE:BRM - Biorem Stock Price, Forecast & News

+0.05 (+19.23 %)
(As of 04/1/2020 03:22 AM ET)
Today's Range
Now: C$0.31
50-Day Range
MA: C$0.37
52-Week Range
Now: C$0.31
Volume3,000 shs
Average Volume26,655 shs
Market CapitalizationC$11.64 million
P/E Ratio2.33
Dividend YieldN/A
BIOREM Inc., an environmental biotechnology company, designs, manufactures, and sells air emissions control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs) in Canada, the United States, China, and internationally. It offers biofilters for the removal of odors, H2S, VOCs and HAPs; and biotrickling filters for applications of high concentrations of H2S or other water soluble compounds. The company also provides multi-stage systems to treat odors associated with various municipal wastewater treatment processes; biogas conditioning systems; ultrafiltration membranes to treat water sources; biological odor control systems; and filter media products to treat air emissions. In addition, it offers biological processes and testing services; media sampling and analysis; system review and inspections; and media replacements and spare parts. The company is headquartered in Guelph, Canada.
Read More

Industry, Sector and Symbol

Industry Pollution & Treatment Controls



Sales & Book Value

Annual SalesC$27.15 million
Cash FlowC$0.14 per share
Book ValueC$0.35 per share



Market CapC$11.64 million
Next Earnings DateN/A
OptionableNot Optionable

Receive BRM News and Ratings via Email

Sign-up to receive the latest news and ratings for BRM and its competitors with MarketBeat's FREE daily newsletter.

Biorem (CVE:BRM) Frequently Asked Questions

How has Biorem's stock been impacted by COVID-19 (Coronavirus)?

Biorem's stock was trading at C$0.38 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, BRM stock has decreased by 17.3% and is now trading at C$0.31. View which stocks have been mosted impacted by Coronavirus.

Has Biorem been receiving favorable news coverage?

Media coverage about BRM stock has trended very negative recently, according to InfoTrie Sentiment. The research group rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Biorem earned a news impact score of -3.0 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 4.0 out of 10, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutBiorem.

Who are some of Biorem's key competitors?

What other stocks do shareholders of Biorem own?

Who are Biorem's key executives?

Biorem's management team includes the following people:
  • Mr. Derek S. Webb, CEO, Pres & Director
  • Mr. Douglas Newman, CFO & Sec.

What is Biorem's stock symbol?

Biorem trades on the Canadian Venture Exchange (CVE) under the ticker symbol "BRM."

How do I buy shares of Biorem?

Shares of BRM and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Biorem's stock price today?

One share of BRM stock can currently be purchased for approximately C$0.31.

How big of a company is Biorem?

Biorem has a market capitalization of C$11.64 million and generates C$27.15 million in revenue each year.  View additional information about Biorem.

What is Biorem's official website?

The official website for Biorem is http://www.biorem.biz/.

How can I contact Biorem?

Biorem's mailing address is 7496 Wellington Road 34, R.R. #3, GUELPH, ON N1H 6H9, Canada. The company can be reached via phone at +1-519-7679100.

MarketBeat Community Rating for Biorem (CVE BRM)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  57 (Vote Outperform)
Underperform Votes:  68 (Vote Underperform)
Total Votes:  125
MarketBeat's community ratings are surveys of what our community members think about Biorem and other stocks. Vote "Outperform" if you believe BRM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BRM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/1/2020 by MarketBeat.com Staff

Featured Article: What is a balanced fund?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel